These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8760247)

  • 1. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways.
    Imig JD; Navar LG
    Am J Physiol; 1996 Jul; 271(1 Pt 2):F87-93. PubMed ID: 8760247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.
    Imig JD; Deichmann PC
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F274-82. PubMed ID: 9277588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure.
    Imig JD; Zou AP; Ortiz de Montellano PR; Sui Z; Roman RJ
    Am J Physiol; 1994 May; 266(5 Pt 2):H1879-85. PubMed ID: 8203587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.
    Imig JD; Pham BT; LeBlanc EA; Reddy KM; Falck JR; Inscho EW
    Hypertension; 2000 Jan; 35(1 Pt 2):307-12. PubMed ID: 10642316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
    Imig JD; Falck JR; Wei S; Capdevila JH
    J Vasc Res; 2001; 38(3):247-55. PubMed ID: 11399897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II.
    Oyekan A; Balazy M; McGiff JC
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R293-300. PubMed ID: 9249563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of epoxygenase metabolites on the preglomerular vasculature.
    Imig JD; Navar LG; Roman RJ; Reddy KK; Falck JR
    J Am Soc Nephrol; 1996 Nov; 7(11):2364-70. PubMed ID: 8959626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cardiac afferents by arachidonic acid: relative contributions of metabolic pathways.
    Sun SY; Wang W; Schultz HD
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H93-H104. PubMed ID: 11406473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels.
    Miura H; Gutterman DD
    Circ Res; 1998 Sep; 83(5):501-7. PubMed ID: 9734472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat.
    Oyekan AO; McGiff JC; Quilley J
    Circ Res; 1991 Apr; 68(4):958-65. PubMed ID: 1901256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction.
    Inscho EW; Cook AK; Mui V; Imig JD
    Hypertension; 1998 Jan; 31(1 Pt 2):421-8. PubMed ID: 9453339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
    Kohagura K; Arima S; Endo Y; Chiba Y; Ito O; Abe M; Omata K; Ito S
    Hypertens Res; 2001 Sep; 24(5):551-7. PubMed ID: 11675950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity.
    Nishiyama A; Inscho EW; Navar LG
    Am J Physiol Renal Physiol; 2001 Mar; 280(3):F406-14. PubMed ID: 11181402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure.
    Ichihara A; Imig JD; Navar LG
    Hypertension; 1999 Oct; 34(4 Pt 2):843-7. PubMed ID: 10523371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid inhibits activity of cloned renal K+ channel, ROMK1.
    Macica CM; Yang Y; Hebert SC; Wang WH
    Am J Physiol; 1996 Sep; 271(3 Pt 2):F588-94. PubMed ID: 8853420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.
    Feng MG; Navar LG
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F310-5. PubMed ID: 20462966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS.
    Ichihara A; Imig JD; Inscho EW; Navar LG
    Am J Physiol; 1998 Oct; 275(4):F605-12. PubMed ID: 9755132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness.
    Imig JD; Falck JR; Inscho EW
    Br J Pharmacol; 1999 Jul; 127(6):1399-405. PubMed ID: 10455289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
    Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G
    Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of sphingosine-1-phosphate-mediated vasoconstriction of rat afferent arterioles.
    Guan Z; Wang F; Cui X; Inscho EW
    Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28640982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.